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SUMMARY 
Necrosis of infected macrophages constitutes a critical pathogenetic event in tuberculosis by 
releasing mycobacteria into the growth-permissive extracellular environment. In zebrafish 
infected with Mycobacterium marinum or Mycobacterium tuberculosis, excess Tumor Necrosis 
Factor triggers programmed necrosis of infected macrophages through the production of 
mitochondrial reactive oxygen species (ROS) and the participation of cyclophilin D, a 
component of the mitochondrial permeability transition pore. Here we show that this necrosis 
pathway is not mitochondrion-intrinsic but results from an inter-organellar circuit initiating and 
culminating in the mitochondrion. Mitochondrial ROS induce production of lysosomal ceramide 
that ultimately activates the cytosolic protein BAX. BAX promotes calcium flow from the 
endoplasmic reticulum into the mitochondrion through ryanodine receptors, and the resultant 
mitochondrial calcium overload triggers cyclophilin D-mediated necrosis. We identify 
Ryanodine receptors and plasma membrane L-Type calcium channels as druggable targets to 
intercept mitochondrial calcium overload and necrosis of mycobacterium-infected zebrafish and 
human macrophages. 
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HIGHLIGHTS 
TNF induces mitochondrial ROS to cause necrosis of mycobacterium-infected macrophages  
Mitochondrial ROS activate lysosomal enzymes that lead to BAX activation  
BAX activates ER ryanodine receptors to cause Ca+ flow into the mitochondrion 
Drugs preventing mitochondrial Ca+ overload prevent pathogenic macrophage necrosis in TB  
 
eTOC 
When TNF, a protective cytokine in tuberculosis, is produced in excess it becomes detrimental 
by causing pathogenic macrophage necrosis. Roca and colleagues show that TNF can cause 
infected macrophages to produce mitochondrial reactive oxygen species that initiate an elaborate 
signaling circuit traversing multiple organelles and ultimately resulting in mitochondrial calcium 
overload and necrosis.  
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INTRODUCTION 
 The pathogenic life cycle of Mycobacterium tuberculosis (Mtb), the agent of human 
tuberculosis is fueled by its multiple interactions with host macrophages (Cambier et al., 2014; 
Srivastava et al., 2014). Mycobacteria use macrophages to traverse host epithelial barriers to 
enter deeper tissues, where they recruit additional macrophages to form granulomas, 
pathognomonic structures that can serve as intracellular bacterial growth niches (Cambier et al., 
2014; Ramakrishnan, 2012). Granuloma macrophages can undergo necrosis, a key pathogenic 
event that further increases bacterial growth in the more permissive extracellular milieu 
(Divangahi et al., 2013; Ramakrishnan, 2012), thereby increasing disease morbidity and 
transmission (Cambier et al., 2014; Huang et al., 2014; Reichler et al., 2002).  
 Mycobacterium-macrophage interactions and resultant macrophage fates can be detailed 
in the optically transparent zebrafish larva infected with Mycobacterium marinum (Mm), a close 
genetic relative of Mtb (Pagan and Ramakrishnan, 2014; Takaki et al., 2013). In this model, 
distinct host genetic mutations that increase macrophage necrosis render the host 
hypersusceptible by promoting unrestricted extracellular mycobacterial growth (Berg et al., 
2016; Clay et al., 2008; Pagan et al., 2015; Tobin et al., 2012). One genetic perturbation that 
produces hypersusceptibility through macrophage necrosis increases expression of leukotriene 
A4 hydrolase (LTA4H), which catalyzes the final step in the synthesis of the inflammatory lipid 
mediator leukotriene B4 (LTB4) (Tobin et al., 2012). Humans with a functional LTA4H promoter 
variant that increases LTA4H expression are also hypersusceptible to TB (Thuong et al., 2017; 
Tobin et al., 2012). Among a case-cohort of tuberculous meningitis, the severest form of TB, 
LTA4H-high individuals had increased risk of death. Consistent with inflammation-induced 
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mortality, survival was dramatically increased among patients who received adjunctive anti-
inflammatory therapy with glucocorticoids (Thuong et al., 2017; Tobin et al., 2012).  
 The human relevance of the zebrafish findings provided the impetus to carry out a 
detailed mechanistic dissection of the necrosis pathway. In the zebrafish, we showed that 
susceptibility of the LTA4H-high state is due to the excessive production of the pro-
inflammatory cytokine TNF that, at optimal levels is host protective (Tobin et al., 2012). Excess 
TNF triggers RIPK1- and RIPK3-dependent programmed necrosis of mycobacterium-infected 
macrophages, but not uninfected macrophages in the same animal (Roca and Ramakrishnan, 
2013). TNF-RIPK1-RIPK3 interactions increase mitochondrial reactive oxygen species (ROS) 
production, which are required for necrosis along with cyclophilin D, a mitochondrial matrix 
protein (Roca and Ramakrishnan, 2013). Oxidative stress can trigger cyclophilin D, which 
promotes sustained opening of the mitochondrial permeability transition pore complex (mPTP);  
this leads to disruption of the membrane potential and ATP depletion (Baines, 2010; Bernardi, 
2013; Halestrap et al., 2004; Nakagawa et al., 2005). So the dual requirement for mitochondrial 
ROS and cyclophilin D would be consistent with a mitochondrion-intrinsic necrosis pathway 
where TNF-induced mitochondrial ROS activate cyclophilin D (Figure 1A).  
 However, we found that necrosis also requires lysosomal components, specifically 
ceramide produced by lysosomal acid sphingomyelinase (aSM) (Roca and Ramakrishnan, 2013) 
(Figure 1A). In this work, we have sought to understand why lysosomal ceramide would be 
required for mitochondrially mediated necrosis (Figure 1A). We show that TNF-mediated 
necrosis results from a single pathway, an inter-organellar circuit that initiates in the 
mitochondrion and traverses the lysosome, cytosol, and endoplasmic reticulum (ER) before 
returning to the mitochondrion to execute necrosis. This intricate circuit that begins with 
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mitochondrial ROS production ultimately results in mitochondrial Ca2+ overload, which is a 
likely trigger for cyclophilin D activation (Baines et al., 2005; Nakagawa et al., 2005). We find 
that Mycobacterium tuberculosis (Mtb), like Mm triggers this pathway in the zebrafish, and both 
Mm and Mtb cause TNF-mediated necrosis of human macrophages. Elucidating this pathway 
has led to the identification of multiple commonly-used drugs that inhibit TNF-induced necrosis 
of mycobacterium-infected macrophages by preventing mitochondrial Ca2+ overload. 
 
RESULTS 
TNF-mediated necrosis is dependent on Cathepsin D, BID and BAX 
 Why might necrosis, which could be completed in a mitochondrion-intrinsic fashion 
(Baines, 2010; Bernardi, 2013; Zamzami et al., 2005), require lysosomal components? The 
literature revealed a series of clues to this conundrum. Lysosomal ceramide mediates TNF-
induced caspase-independent programmed cell death in a fibroblast cell line (Dumitru and 
Gulbins, 2006; Heinrich et al., 2004; Taniguchi et al., 2015; Thon et al., 2005). In vitro, ceramide 
produced by acid sphingomyelinase activates lysosomal proteases, including Cathepsins B and D 
(Heinrich et al., 2004; Heinrich et al., 1999; Taniguchi et al., 2015). In cell-free assays and in 
cultured cells, Cathepsins B and D cleave the pro-apoptotic protein BID to its active form tBID 
(Appelqvist et al., 2012; Cirman et al., 2004; Droga-Mazovec et al., 2008; Heinrich et al., 2004). 
tBID activates BAX, an effector of apoptosis (Westphal et al., 2014), and the cancer 
chemotherapy drug gemcitabine promotes BAX-dependent apoptosis of a glioma cell line via 
lysosomal ceramide accumulation and Cathepsin D activation (Dumitru et al., 2009). BAX is 
reported to work in conjunction with cyclophilin D to induce mitochondrion-intrinsic necrosis 
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(Karch et al., 2013; Karch et al., 2017; Whelan et al., 2012). Collectively, these findings led us to 
consider that lysosomal components mediate necrosis; lysosomal ceramide activates Cathepsin B 
and/or Cathepsin D, which in turn activate(s) BID and thereby recruits BAX.  
 If this sequence is operant, then inhibiting Cathepsin B and/or D, BID and BAX should 
inhibit TNF-mediated macrophage necrosis. To assess this, we injected larvae with TNF one day 
post-infection (dpi) to create TNF-high animals (see STAR methods). TNF-high animals display 
loss of granuloma cellularity at 2-3 days that renders bacteria extracellular (Figure 1B, compare 
control granuloma in top left panel to TNF-high granuloma in top right panel). Extracellular 
bacteria grow more profusely (Figure 1B, compare growth from 3 to 5 dpi in control and TNF-
high granulomas), with a characteristic cording morphology (Figure 1B bottom right panel). The 
presence of bacterial cording is a reliable, facile, quantifiable indicator that granuloma 
macrophage necrosis has occurred within the animal (Clay et al., 2008; Tobin et al., 
2012)(Figure 1C). We inhibited Cathepsins B and D, respectively, using the cysteine Cathepsin 
inhibitor E64d and the aspartyl Cathepsin inhibitor pepstatin A (Baldwin et al., 1993; Berg et al., 
2016). Only pepstatin A inhibited TNF-mediated necrosis, pinpointing Cathepsin D (Figure 1D 
and 1E). We confirmed Cathepsin D’s involvement with genetic Cathepsin D depletion using an 
antisense morpholino (Follo et al., 2011): Cathepsin D morphants were resistant to TNF necrosis 
(Figure 1F). Morpholino-mediated BID knockdown and pharmacological inhibition with BI-
6C9, a small molecule tBID inhibitor (Becattini et al., 2004) also inhibited necrosis (Figure 1G 
and 1H).  
 Next, we asked if BAX was involved. There are two zebrafish paralogs of human BAX - 
BAXA and BAXB, with BAXA more similar to human BAX (Kratz et al., 2006)(Figure S1A 
and S1B). We tested the roles of the two BAX homologs in camptothecin-induced apoptosis, a 
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BAX-dependent process in mammals (Albihn et al., 2007) Zebrafish BAXA mutants displayed 
the greater reduction in apoptosis (Figure S1C and D). Furthermore, BAXA mutants were 
resistant to TNF-mediated necrosis whereas BAXB mutants were susceptible (Figure 1I and 
Figure 1J). These results show that BAX, specifically BAXA, is required for necrosis. We will 
refer to BAXA as BAX hereon. In sum, our findings are consistent with lysosomal ceramide 
mediating necrosis through Cathepsin D activation leading to BID and thereby BAX activation.  
BAX’s role in TNF-mediated necrosis is independent of oligomerization  
 BAX is thought to participate in mitochondrion-mediated apoptosis through recruitment  
and oligomerization on the mitochondrial outer membrane to form pores (Dewson and Kluck, 
2009). It has also been reported to target the mitochondrial outer membrane to mediate necrosis 
in conjunction with cyclophilin D in the inner mitochondrial membrane (Karch et al., 2015; 
Karch et al., 2013; Whelan et al., 2012). Different studies report this role as either dependent or 
independent of oligomerization, which requires its BH3 domain (Karch et al., 2015; Karch et al., 
2013; Whelan et al., 2012) (Figure 2A). To test if BAX oligomerization was required in TNF-
mediated necrosis, we expressed BAX lacking the BH3 domain (BH3-BAX) in BAX-deficient 
animals (Figure 2A). We confirmed the BH3 domain was required for apoptosis: as previously 
shown (Kratz et al., 2006), expression of full length BAX in newly-fertilized BAX-deficient 
zebrafish eggs was rapidly lethal (due to exacerbated apoptosis), whereas BH3-BAX expression 
was not (Figure S2A). BAX mutants expressing BH3-BAX also remained resistant to 
camptothecin-mediated apoptosis (Figure S2B). In contrast, BH3-BAX restored TNF-mediated 
necrosis in BAX mutants, showing that BAX oligomerization and pore formation were not 
required (Figure 2B). Furthermore, BCB (BAX Channel Blocker), a small molecule inhibitor of 
BAX channel forming activity and cytochrome C release required for apoptosis (Cui et al., 
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2017), inhibited camptothecin-mediated apoptosis but not macrophage necrosis (Figure 2C and 
S2C). These results show that BAX functions in TNF-mediated necrosis independent of its 
oligomerization and pore-forming activity. 
BAX’s role in TNF-mediated necrosis does not require its localization to the outer 
mitochondrial membrane  
 Prior reports described a necrosis pathway where non-oligomerizing BAX interacts with 
the mitochondrial outer membrane to mediate necrosis in conjunction with cyclophilin D acting 
in the inner membrane (Karch et al., 2013; Whelan et al., 2012). If this occurs in TNF-mediated 
necrosis, then expression of BH3-BAX targeted to the mitochondrial outer membrane should be 
sufficient to restore necrosis in BAX-deficient animals. Strikingly, it did not (Figure 2D). We 
confirmed that the mitochondrial tag did not disrupt BAX activity by showing that the apoptotic 
function of mitochondrially-tagged full length BAX was intact. Expression of the construct was 
lethal to newly-fertilized BAX-deficient eggs (Figure S2D). Therefore, BAX’s role in TNF-
mediated cyclophilin D-dependent necrosis is not through targeting the mitochondrial outer 
membrane. 
BAX mediates necrosis by promoting Ca2+ translocation from the ER to the mitochondrion 
 How might BAX facilitate cyclophilin D-dependent necrosis? In addition to its 
mitochondrial interactions, BAX is reported to regulate calcium release from the ER (Rong and 
Distelhorst, 2008). Because mitochondrial Ca2+ overload, as well as oxidative stress, is known to 
be a trigger for cyclophilin D-dependent necrosis (Clarke et al., 2002; Halestrap, 2005), we 
wondered if BAX worked in TNF-mediated necrosis by facilitating Ca2+ flow from the ER to the 
mitochondrion to cause this overload. This model leads to five predictions: 1) TNF-mediated 
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necrosis should be associated with mitochondrial Ca2+overload, 2) Inhibiting mitochondrial 
Ca2+ overload should rescue necrosis, 3) Mitochondrial Ca2+overload should be BAX-dependent 
as well as dependent on its upstream activators, 4) BAX’s action in the ER should be sufficient 
for mitochondrial Ca2+overload and necrosis and 5) Reducing ER Ca2+ stores should prevent 
necrosis. 
 We used two approaches to test if mitochondrial Ca2+overload was linked to necrosis. 
First, we visualized mitochondrial Ca2+ in animals expressing the genetically-encoded Ca2+ 
indicator GCaMP3 specifically in mitochondria (Esterberg et al., 2014). TNF increased the 
intensity of GCaMP3 fluorescence only in infected macrophages within 90 minutes, indicating 
that it promoted mitochondrial Ca2+ uptake (Figure 2E and 2F), consistent with TNF causing 
necrosis specifically in infected macrophages (Roca and Ramakrishnan, 2013). In a 
complementary approach, we used Rhod-2, a fluorescent chemical probe for Ca2+ that 
accumulates in mitochondria (Smolina et al., 2014). Again infected, but not uninfected, 
macrophages became Rhod-2-positive within 120 minutes of TNF administration (Figure 2G and 
2H). Mitochondrial Ca2+ overload in infected macrophages was rapidly followed by necrosis; in 
contrast, infected macrophages without Ca2+ overload did not die (Figure 2I). Thus, TNF caused 
mitochondrial Ca2+ overload selectively in infected macrophages and mitochondrial Ca2+ 
overload preceded necrosis.  
 To test if inhibiting mitochondrial Ca2+ overload rescues necrosis, we treated animals 
with Ru360, an inhibitor of the mitochondrial Ca2+ uniporter (MCU), the major route of Ca2+ 
entry into the mitochondrial matrix (Zazueta et al., 1999).  Ru360 prevented the Ca2+ overload 
seen in TNF-high animals at five hours (Figure 3A), and inhibited macrophage necrosis at 5dpi 
(Figure 3B). Thus, Ca2+ overload is a prerequisite for macrophage necrosis. Mitochondrial Ca2+ 
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overload was absent in BAX-, ceramide-, Cathepsin D- and BID-deficient animals (Figure 3C-
3E), indicating that BAX and its upstream activators were required for mitochondrial Ca2+ 
overload. To test if BAX causes mitochondrial Ca2+ overload solely by acting in the ER, we 
expressed ER-targeted BH3-BAX in BAX-deficient animals. ER-targeted BH3-BAX restored 
TNF-mediated mitochondrial Ca2+ overload and macrophage necrosis in BAX-deficient animals, 
similar to untargeted BH3-BAX (Figure 3F and 3G).  
 To test if reducing ER Ca2+ prevents TNF-mediated necrosis, we used two approaches. 
First, we used thapsigargin to inhibit activity of ER membrane-resident SERCA proteins that 
transfer Ca2+ from the cytosol into the ER lumen (Chemaly et al., 2018); thapsigargin depletes 
ER Ca2+ while increasing cytosolic Ca2+ (Inesi and Sagara, 1992; Iwasaki et al., 2015). 
Thapsigargin treatment reduced macrophage mitochondrial Ca2+ overload and reduced necrosis 
(Figure 3H and 3I). Second, we overexpressed the ER Ca2+ leak channels TMBIM 3 and 6 in the 
animals to reduce steady state ER Ca2+ concentrations (Lisak et al., 2015). Overexpression of 
either TMBIM 3 or 6 inhibited TNF-mediated mitochondrial Ca2+ overload and macrophage 
necrosis (Figure 3J and 3K). These findings revealed the ER, not the mitochondrion, is the target 
of activated BAX in TNF-mediated necrosis of Mm-infected macrophages, and that BAX 
activation is required for Ca2+ translocation from the ER to the mitochondrion.  
BAX mediates direct Ca2+ flow from the ER to the mitochondrion through Ryanodine 
receptors 
 We searched for mechanisms by which BAX causes ER to mitochondrion Ca2+ 
translocation with resultant mitochondrial Ca2+ overload. Apoptosis can feature ER to 
mitochondrion Ca2+ translocation through the IP3 receptor (IP3R) (Jayaraman and Marks, 1997; 
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Vance, 2014). To test if BAX was promoting mitochondrial Ca2+ transit through IP3R, we took 
advantage of the finding that BCL2 binds and inhibits IP3R through its BH4 domain (Rong et al., 
2009). Expression of the 28-amino acid BCL2 BH4 domain inhibited mitochondrial Ca2+ 
overload and necrosis, suggesting IP3R involvement (Figure 4A and 4B). Surprisingly, 
xestospongin C, a specific IP3R inhibitor, which is active in the zebrafish (Esterberg et al., 
2014), did not inhibit mitochondrial Ca2+ overload and necrosis (Figure 4C and 4D). In 
reconciling the disparity between the xestospongin C and BCL2 BH4 effects, we realized that 
BCL2 BH4 also inhibits another group of ER Ca2+ channels, the Ryanodine receptors (RyR) 
(Vervliet et al., 2014; Vervliet et al., 2016). While RyR activity is recognized in excitable cell 
types, they are expressed in both human and zebrafish monocytes/macrophages (Table S1). To 
ask if RyR were involved in this pathway, we took advantage of the finding that only RyR, and 
not IP3R, are inhibited by the BH4 domain of BCL-XL (Vervliet et al., 2015). BCL-XL BH4 
inhibited mitochondrial Ca2+ overload and necrosis similar to BCL-2 BH4, suggesting RyR 
involvement (Figure 4A and 4E). This was confirmed by showing that the specific RyR inhibitor 
ryanodine inhibited TNF-mediated mitochondrial Ca2+ overload and macrophage necrosis 
(Figure 4C and 4D). Another specific RyR inhibitor dantrolene, an approved human drug, did as 
well (Zhao et al., 2001)(Figure 4F and 4G). Conversely, we asked if pharmacological activation 
of RyR with 4CmC (Jacobson et al., 2006) restored TNF-mediated necrosis in BAX mutants. We 
first confirmed 4CmC activity in the zebrafish by showing that it increased mitochondrial Ca2+ 
(Figure 4H). 4CmC did restore TNF-mediated necrosis in BAX mutants, and this was blocked by 
inhibiting mitochondrial Ca2+ uptake with Ru360 (Figure 4I). Thus, BAX acts at the ER through 
RyR to cause mitochondrial Ca2+ overload and necrosis.  
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 TNF-induced mitochondrial ROS cause activation of lysosomal aSM that ultimately 
results in mitochondrial Ca2+ overload 
 We now understood that the lysosomal pathway ultimately converged into the 
mitochondrion to cause cyclophilin D-dependent necrosis. But how does TNF trigger lysosomal 
ceramide production in infected macrophages? Because aSM has been shown to be a redox 
sensitive enzyme (Dumitru and Gulbins, 2006), we hypothesized that TNF first induces 
mitochondrial ROS, which activate lysosomal components that ultimately cause mitochondrial 
Ca2+ overload. If mitochondrial ROS are ultimately responsible for mitochondrial Ca2+ overload, 
then: 1) they should precede mitochondrial Ca2+ overload 2) removing mitochondrial ROS 
should remove Ca2+ overload. Using two different fluorogenic probes to detect ROS specifically 
in the mitochondrion, MitoTracker Red CM-H2Xros and MitoSOX, we found that mitochondrial 
ROS were induced within 40 minutes after TNF administration to the animals, the first time 
point that it was technically feasible to image them (Figure S3A-S3D). As expected, increased 
mitochondrial ROS production was seen only in infected macrophages (Roca and Ramakrishnan, 
2013)(Figure S3B and S3D). Mitochondrial ROS appeared to precede mitochondrial Ca2+ 
overload, first apparent at 90 minutes post TNF (Figure 2I). We confirmed this by assessing 
them in the same experiment (Figure 5A). Mitochondrial ROS were robustly detected at 58 
minutes, the first observation time point, and did not increase further over the 40-minute 
observation period. Mitochondrial Ca2+ was first detected at 71 minutes, increasing further over 
the observation period. Having shown that mitochondrial ROS precede mitochondrial Ca2+ 
overload, we tested if removing mitochondrial ROS would remove Ca2+ overload. Multiple ROS 
scavengers previously shown to inhibit TNF-mediated necrosis, including the mitochondrion-
specific antioxidant MitoTEMPO (Roca and Ramakrishnan, 2013), eliminated mitochondrial 
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Ca2+ overload (Figure 5B). Moreover, RIPK1, RIPK3 and PGAM5, determinants shown to be 
downstream of TNF and required for mitochondrial ROS production (Roca and Ramakrishnan, 
2013) were also required for mitochondrial Ca2+ overload - RIPK1 inhibition with necrostatin-1 
and genetic inhibition of RIPK3 and PGAM5 removed both mitochondrial ROS (Figure 5C) and 
Ca2+ overload (Figure 5D). These results confirmed that mitochondrial ROS are required for 
Ca+ overload.  
 We confirmed the order of the pathway with genetic and pharmacological manipulations 
of TNF-high animals. Ceramide, Cathepsin D, BID and BAX, and RyR which were upstream of 
mitochondrial Ca2+ overload (Figures 3C-3E and 4C and 4F), were found to be downstream of 
mitochondrial ROS, as predicted - TNF-induced ROS were preserved upon aSM inhibition with 
desipramine, in Cathepsin D and BID morphants, in BAX mutants, and upon RyR inhibition 
with dantrolene (Figure 5E and 5F).  
 Finally, our model predicts that cyclophilin D mediates necrosis downstream of both 
mitochondrial ROS and Ca2+ overload. To test this, we blocked cyclophilin D activity genetically 
and pharmacologically as previously shown (Roca and Ramakrishnan, 2013). Cyclophilin D 
morphants and alisporivir-treated animals preserved both mitochondrial ROS and Ca2+ overload 
(Figure 5G and 5H) yet, as previously shown, did not manifest necrosis (Figure 5I). Together 
these findings show that mitochondrial ROS initiate the circuit and confirm the predicted order 
of the components. 
Pharmacological inhibition of cellular Ca2+ uptake inhibits TNF-mediated macrophage 
mitochondrial Ca2+ overload and necrosis in Mm- and Mtb-infected animals 
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 Given the critical role of mitochondrial Ca2+ overload in necrosis, we wondered if 
reducing Ca2+ uptake in macrophages would lower steady state ER Ca2+ levels sufficiently to 
prevent mitochondrial Ca2+ overload. Nifedipine, diltiazem and verapamil represent different 
classes of drugs that inhibit voltage gated L-type calcium channels (LTCCs) located in the 
plasma membrane (Zamponi et al., 2015). While LTCCs were thought to be restricted to 
excitable cells, recent work has found them to be more broadly expressed, including in immune 
cells (Davenport et al., 2015; Espinosa-Parrilla et al., 2015). Importantly, LTCCs are present in 
human, mouse and zebrafish myeloid cells, and modulate activation and cytokine production of 
human blood monocytes and alveolar macrophages (Antony et al., 2015; Athanasiadis et al., 
2017; Ebina-Shibuya et al., 2017) (www.proteinatlas.org; www.immgen.org). We asked if the 
nifedipine, diltiazem and verapamil inhibit mitochondrial Ca2+ overload and macrophage 
necrosis in TNF-high animals, and found that they did (Figure 6A-6D).   
 Our findings thus far showed this TNF-induced necrosis pathway is operant only in Mm-
infected macrophages, with Mm required to induce mitochondrial ROS production in a 
macrophage-intrinsic fashion (Roca and Ramakrishnan, 2013) (Figure S3B and S3D). The 
therapeutic potential of the LTCC inhibitors in inhibiting pathogenic necrosis in human TB 
prompted us to check if Mtb similarly colludes with TNF to trigger this pathway. Virulent Mtb is 
a biosafety level 3 pathogen that we could not use in our biosafety level 2 zebrafish facilities. So 
we used the double leucine and pantothenate auxotroph of Mtb (Mtb leuD panCD), a 
biosafety level 2 pathogen owing to its inability to grow in vivo (Sampson et al., 2011). After 
confirming that Mtb leuD panCD persisted within zebrafish macrophages at 1 dpi (Figure 
6E), we assessed early readouts of the pathway - macrophage mitochondrial ROS and 
mitochondrial Ca2+ overload. In agreement with the results from Mm infections, Mtb-infected 
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macrophages of TNF-high animals displayed higher levels of mitochondrial ROS production and 
Ca2+ overload than infected macrophages in control animals (Figure 6F and 6G). Uninfected ones 
did not, as expected (data not shown). Importantly, the RyR inhibitor dantrolene and the LTCC 
inhibitors removed the mitochondrial Ca2+ overload from both Mtb and Mm (Figure 6G). In sum, 
Mtb, like Mm, co-opts host TNF to mediate macrophage necrosis, and dantrolene and the LTCC 
targeting drugs inhibit this pathogenic event, whether initiated by Mm or Mtb (Figure 7A). 
The TNF-mediated necrosis pathway occurs in mycobacterium-infected human 
macrophages 
 If Mtb, a human pathogen, induces the necrosis pathway in the zebrafish, then the 
pathway is likely to be operant in human macrophages. To test this, we used macrophages 
derived from the human monocytic cell line THP-1, which express RyR and LTCCs, 
(Supplemental Table 1)(www.proteinatlas.org). The zebrafish findings lead to four testable 
predictions for human macrophages: 1) TNF increases death of infected but not uninfected 
macrophages; 2) TNF-induced death occurs through RIPK1-mediated necrosis, i.e. it is RIPK1-
dependent and caspase-independent; 3) it is dependent on BID, RyR and mitochondrial Ca2+ 
overload; 4) it is inhibited by inhibiting Ca2+ uptake into the cells. To test these predictions, we 
infected THP-1 macrophages with Mm or Mtb for 24 hours, then added exogenous TNF to the 
culture medium to create a TNF-high state.  Five hours of TNF treatment increased cell death in 
a concentration-dependent fashion in Mm-infected macrophages; this was specific to infected 
cells and spared uninfected cells in the same well and cells in uninfected wells (Figure 7B). The 
highest TNF concentration tested, 10 ng/ml, gave the clearest separation between infected and 
uninfected cells, so we chose it for further experiments. A series of replicate experiments (Table 
S2) confirmed that: TNF increased infected macrophage death (Figure 7C, column 1); in the 
TNF-treated wells, increased death was limited to infected macrophages (Figure 7C, column 2); 
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and TNF did not increase macrophage death in uninfected wells (Figure 7C, column 3). Thus, we 
confirmed that TNF increases death of, and only of, Mm-infected macrophages.  
 To test if infected macrophage death was RIPK1-dependent and caspase-independent, we 
used RIPK1 and pan-caspase inhibitors. The RIPK1 inhibitors necrostatin-1 and Nec-1s 
(Takahashi et al., 2012) inhibited TNF-mediated death whereas the pan-caspase inhibitors Q-
VD-OPh and Z-VAD-FMK did not (Figure 7D and 7E). None of the inhibitors affected death of 
uninfected cells (Figure S4A and S4B). These results confirm that TNF mediates RIPK1-
dependent necrosis selectively in infected human macrophages. Next, we inhibited BID, RyR 
and MCU activity with BI-6C9, dantrolene and Ru360. All inhibited infected, but not uninfected 
macrophage necrosis showing the requirement for BID, RyR and mitochondrial Ca2+ overload 
(Figure 7A and 7F and Figure S4C). We then used the LTCC inhibitors to ask if reducing Ca2+ 
uptake by the macrophages would inhibit necrosis. All three drugs inhibited necrosis specifically 
in infected cells (Figure 7G and Figure S4D). 
 Finally, we confirmed that Mtb-infected human macrophages are susceptible to TNF-
mediated necrosis. TNF increased necrosis of infected but not uninfected macrophages and was 
inhibited by dantrolene and the LTCC inhibitors (Figure 8H). As with Mm, inhibition of death 
by dantrolene and the LTCC inhibitors was specific to infected cells, sparing uninfected cells 
(Figure S4E).  In sum, both Mm and Mtb co-opt TNF to mediate necrosis in human 
macrophages. 
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DISCUSSION 
Our dissection of the mechanism by which an excessive TNF response causes necrosis of 
mycobacterium-infected macrophages has revealed an intricate inter-organellar relay - a circuit 
that begins in the mitochondrion, transits the lysosome, cytosol and ER to complete in the 
mitochondrion (Figure 7A). Active in both zebrafish and human macrophages, this necrosis 
pathway exemplifies important signaling circuits conserved from fish to humans. Given the 
shared pathogenetic programs of Mm and Mtb, particularly in the context of mycobacterium-
macrophage interactions and the tuberculous granuloma (Cambier et al., 2014), it is not 
surprising that signaling networks uncovered in the context of fish TB are conserved in human 
TB. The use of the zebrafish has uncovered this conserved pathogenic necrosis program and 
suggested drugs to inhibit it (Figure 7A). Prior work identified the aSM-inhibiting tricyclic 
antidepressant drug desipramine and the CYPD inhibitor alisporivir to inhibit this necrosis (Roca 
and Ramakrishnan, 2013)(Figure 7A). The more complete understanding of the program 
suggests dantrolene, and most promisingly, the widely-used, inexpensive LTCC inhibitors as TB 
treatments (Figure 7A). These host-targeting drugs should be effective in drug-sensitive and 
drug-resistant TB. 
Our work assigns new functions to, and links between, several participants that execute 
TNF-mediated necrosis in mycobacterium-infected macrophages. We identify BAX as an 
activator of RyR. RyR are Ca2+ translocators enabling activity of excitable tissues; we find 
macrophage activity of these receptors mediates pathology in mycobacterial infection. Our 
dissection of the pathway reveals unexpected interconnections between effector molecules that 
span different organelles. The circuit begins and ends with the transit of two inorganic signals - 
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ROS from mitochondrion to lysosome, and Ca2+ from ER to mitochondrion, and requires 
Cathepsin D translocation from lysosome to cytosol.  
 This pathway does not fit into current classification schemes of regulated cell death 
(Galluzzi et al., 2018), being dependent on RIPK1, RIPK3 and possibly MLKL, similar to 
necroptosis, and on CYPD, similar to CYPD-mediated necrosis. Further confounding current 
categorization, the pathway is dependent on activity of lysosomal Cathepsin D activity in the 
cytosol. Yet it does not display the generalized lysosomal permeabilization that demarcates 
another discrete cell death category, lysosome-dependent cell death (Galluzzi et al., 2018). An 
important player is the mycobacterium whose presence in the macrophage is required for 
mitochondrial ROS production in response to excess TNF (Roca and Ramakrishnan, 2013). 
Whether infection has further roles in executing this necrosis remains to be determined. What is 
clear is that mycobacterium-infected macrophages undergo a specific form of regulated death 
involving multiple organelles and a high degree of cross-talk between components associated 
with different cell death programs (Galluzzi et al., 2018). The idea that necrotic cell death can 
occur through the interplay between multiple signaling pathways rather than a single well-
described one is not new (Festjens et al., 2006; Vanden Berghe et al., 2014). This work reveals 
that the dominant paradigms of cell death are insufficient to explain pathological macrophage 
death in tuberculosis.  
Inter-organellar contacts promote pathogenic macrophage necrosis 
 Ca2+ transfer from ER to mitochondrion is facilitated by physical contacts between them - 
the mitochondria-associated ER membranes (MAMs) (Naon and Scorrano, 2014; Vance, 2014). 
These tight connections allow for direct Ca2+ transit, creating a high Ca2+ concentration in the 
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vicinity of the mitochondrial Ca2+ uniporter MCU, essential for Ca2+ transit through this low 
affinity receptor (Penna et al., 2018). Specifically, RyR-mediated ER-mitochondrial Ca2+ transfer 
is supported by findings showing that RyR activity is directly or indirectly coupled to VDAC,  to 
promote Ca2+ translocation from the ER into the mitochondrion (Fernandez-Sanz et al., 2014; 
Min et al., 2012). Recent studies also find that mitochondrion-lysosome contacts occur at 
appreciable frequency in healthy cells, suggesting a mechanism by which mitochondrial ROS 
can transit to lysosomes (Valm et al., 2017; Wong et al., 2018)(Figure 7A). Our work implicates 
inter-organellar contacts, thought to be part of cellular homeostasis, in disease pathogenesis as 
well.  
Mitochondrial ROS translocate calcium into the mitochondrion through an elaborate inter-
organellar circuit 
 Mitochondrial oxidative stress triggers mitochondrial transition pore opening by 
oxidizing and regulating cyclophilin D activity (Halestrap, 2005; Lopez-Erauskin et al., 2012). 
Therefore it was reasonable to think that TNF-mediated mitochondrial ROS induced necrosis by 
directly activating cyclophilin D (Roca and Ramakrishnan, 2013). Instead, we now find that ROS 
activate lysosomal components that ultimately deliver the Ca2+ into the mitochondrion that is 
essential for necrosis.  These observations are in agreement with previous studies showing that 
Ca2+ regulates cyclophilin D activity and mPTP opening (Baines et al., 2005; Clarke et al., 2002; 
Nakagawa et al., 2005). While mitochondrial ROS may also directly regulate cyclophilin D in 
this pathway, our work shows it is unlikely their predominant role - interventions that remove 
mitochondrial Ca2+ uptake, while maintaining TNF-induced mitochondrial ROS, inhibit 
necrosis almost completely. Thus, mitochondrial ROS alone cannot mediate TNF-induced 
cyclophilin D-dependent necrosis. This work suggests the two inorganic signals co-operate to 
 21 
produce necrosis by each activating an enzyme -  ROS activating the lysosomal enzyme aSM, 
and Ca2+ activating the mitochondrial enzyme cyclophilin D.  
Extralysosomal Cathepsin D function in TNF-mediated necrosis 
 The role assigned to Cathepsin D in TNF-mediated necrosis - cleaving BID to its active 
state - raises the question of how a lysosomal protease makes its way to the cytosol. Lysosomal 
protease release from massive lysosomal disruption can cause necrosis (Turk et al., 2002). 
However, we can infer that Cathepsin D works in TNF-mediated necrosis in the absence of 
massive lysosomal disruption as blocking the pathway immediately downstream of Cathepsin D 
rescues necrosis. Our findings are most consistent with cytosolic translocation of Cathepsin D 
through selective lysosomal membrane permeabilization (Ferri and Kroemer, 2001; Turk et al., 
2002). Local increases in lysosomal ROS and sphingosine can produce lysosome selective 
disruptions, and oxidative stress is associated with Cathepsin D cytosolic translocation (Ferri and 
Kroemer, 2001; Kagedal et al., 2001). Mitochondrial ROS that reaches the lysosome may play 
the dual role of activating aSM and permeabilizing the lysosomal membrane, thus coordinating 
Cathepsin D activation and release into the cytosol. Lysosomal ceramide is converted to 
sphingosine, so overproduction of ceramide might also increase lysosomal sphingosine, which 
could further promote lysosomal permeabilization. 
 Cathepsin D is documented to function in the cytosol in multiple contexts (Benes et al., 
2008). It can cleave BID at neutral pH in vitro, which explains its retaining activity in the cytosol 
(Appelqvist et al., 2012). Our findings do raise the question of why Cathepsin D (and not 
Cathepsin B) is specifically required in the pathway given that both Cathepsins are activated by 
ceramide in vitro and are translocated in response to oxidative stress to the cytosol where both 
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can cleave BID (Appelqvist et al., 2012; Heinrich et al., 2004; Kagedal et al., 2001). One 
possible explanation is that “emergency” cytosolic protease inhibitors e.g., cystatins, can inhibit 
cysteine proteases like Cathepsin B but no such inhibitors have yet been identified for the sole 
lysosomal aspartyl protease Cathepsin D (Turk et al., 2002). Notably, earlier work on Cathepsin 
D deficient mice already highlighted the importance of Cathepsin D’s extralysosomal function - 
Cathepsin D deficient mice were found to maintain normal bulk lysosomal proteolysis while 
undergoing widespread tissue destruction and early death (Saftig et al., 1995). The elaborate 
mechanisms that enable Cathepsin D cytosolic activity and translocation are rooted in the 
requirement for its homeostatic proteolytic function. Our work now highlights that these same 
mechanisms in overdrive can enable TB pathogenesis. 
BAX as an activator of RyR to cause Ca2+ translocation in mycobacterium-infected 
macrophages 
 It is now appreciated that BAX, initially identified as a mediator of apoptosis, participates 
in necrosis and autophagy (Irrinki et al., 2011; Karch et al., 2015; Karch et al., 2017; Tischner et 
al., 2012; Whelan et al., 2012). In most cases, its function is disrupting organellar membranes - 
predominantly the mitochondrion but also ER and lysosome - generally through oligomerization 
to form pores or destabilizing membranes through other means (Feldstein et al., 2006; Karch et 
al., 2015; Karch et al., 2017; Whelan et al., 2012).  
BAX is also implicated in maintaining ER Ca2+ levels, by sequestering BCL-2, which can reduce 
ER Ca2+ through interactions with multiple Ca2+ channels (Bonneau et al., 2013; Vervliet et al., 
2016). We now find a new function for BAX as a translocator of Ca2+ from the ER to the 
mitochondrion by modulating RyR activation. Whether its action is direct or indirect remains to 
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be determined, but we know it occurs independently of its oligomerization and pore forming 
function.  
 The involvement of RyR rather than IP3R is another unexpected element. IP3R are 
ubiquitously present, trigger Ca2+ release in all cells; IP3R activity can promote apoptotic cell 
death by enabling mitochondrial Ca2+ overload through ER MAMs (Vervliet et al., 2016). We 
now find a similar role for RyR, which are thought to induce rapid translocation of Ca2+ in the 
context of nerve and muscle excitation (Lanner et al., 2010). Their expression in macrophages 
across species suggests that they must mediate Ca2+ transfer in nonexcitable cells as well, 
perhaps with different kinetics. Our findings highlight this function, albeit in a pathological 
context, and we show that dantrolene can inhibit its detrimental role. 
Dysregulated TNF as a general cause of tuberculous granuloma necrosis  
Our quest to understand the detailed mechanism of TNF-mediated macrophage necrosis in the 
zebrafish was instigated by its potential relevance for TB severity and treatment in humans with 
a common genetic LTA4H variant that produces a hyperinflammatory state (Thuong et al., 2017; 
Tobin et al., 2012). However, it is likely that high LTA4H and TNF levels may be in play locally 
to produce granuloma necrosis even independently of LTA4H genotype. Spatial studies 
combining mass spectrometry with confocal microscopy of dissected human tuberculous 
granulomas show that necrotic tuberculous granulomas are enriched for LTA4H and TNF as 
compared to nonnecrotic granulomas from the same lung (Marakalala et al., 2016). 
Lactosylceramide, a downstream product of ceramide that is increased in cells by pro-
inflammatory cytokines, is also increased in human lung necrotic granulomas (Chatterjee and 
Pandey, 2008; Kim et al., 2010). This lactosylceramide may reflect further metabolism of acid 
 24 
sphingomyelinase-derived ceramide in granuloma macrophages undergoing TNF-mediated 
necrosis. Thus, the TNF-initiated circuit we have identified may well play a wide role in 
tuberculous granuloma necrosis.  
 Deciphering TB pathogenesis has revealed new cell biology and signaling circuitry. 
Many noninfectious inflammatory conditions feature programmed necrosis that may be 
detrimental (Zhou and Yuan, 2014)  It is conceivable that some are the result of the pathway we 
have identified, initiated by dysregulated TNF coupled to a second trigger to induce 
mitochondrial ROS. Finally, the identification of mitochondrial calcium overload as a requisite 
for necrosis led us to ask if drugs that block LTCCs would reduce Ca2+ entry into the 
macrophage itself, and thereby prevent the pathological mitochondrial overload required for 
necrosis. Our finding that a panel of widely-used calcium channel blocking drugs prevent both 
mitochondrial Ca2+ overload and necrosis suggests a potential for these drugs for TB sufferers 
with LTA4H-high genotype, and possibly more generally for TB as well as other inflammatory 
necroses where this pathway might be operant. Finally, we note that the LTCC inhibitor 
verapamil also inhibits mycobacterial drug tolerance through its action on bacterial drug efflux 
pumps by a different mechanism (Adams et al., 2014; Adams et al., 2011; Gupta et al., 2013). In 
this light, verapamil holds particularly exciting prospects as an adjunctive agent in TB by dually 
blocking detrimental bacterial and host processes.  
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
   
Bacterial and Virus Strains  
Mycobacterium marinum M strain transformed with 
pMSP12:tdTomato 
(Takaki et al., 2013) derivatives of ATCC 
#BAA-535 
M. marinum M strain transformed with pMSP12:EBFP2 (Takaki et al., 2013) derivatives of ATCC 
#BAA-535 
M. marinum M strain transformed with 
pMSP12:tdKatushka 
(Takaki et al., 2013) derivatives of ATCC 
#BAA-535 
M. marinum M strain transformed with pMSP12:wasabi (Takaki et al., 2013) derivatives of ATCC 
#BAA-535 
M. tuberculosis ΔleuD ΔpanCD double auxotroph strain 
transformed with pMSP12:mCherry 
D. Floto Laboratory  N/A 
M. tuberculosis ΔleuD ΔpanCD double auxotroph strain 
transformed with pMSP12:GFP 
D. Floto Laboratory  N/A 
   
Biological Samples 
   
Chemicals, Peptides, and Recombinant Proteins 
Zebrafish recombinant TNF (Roca et al., 2008) N/A 
Pepstatin A Sigma-Aldrich Cat#P4265; 
CAS: 26305-03-3 
E64d Sigma-Aldrich Cat#E8640; 
CAS: 88321-09-9 
BI-6C9 Sigma-Aldrich Cat#B0186; 
CAS: 791835-21-7 
(S)-(+)-Camptothecin (CPT) Alfa Aesar Cat#J62523; 
CAS: 7689-03-4 
Acridine orange (2% solution in H2O) Sigma-Aldrich Cat#A9231; 
CAS: 65-61-2 
BCB (Bax Channel Blocker) Alfa Aesar Cat#J64257 
Rhod-2, AM, cell permeant Fisher Scientific Cat#R1245MP 
Ru360 VWR International Cat#557440 
Amifostine Cambridge Bioscience Cat#14398-50mg-
CAY 
NAC (N-Acetyl-L-Cysteine) Cambridge Bioscience Cat#A0918-10 g 
Mitotempo Cambridge Bioscience Cat#16621-5mg-
CAY 
GSH Cambridge Bioscience Cat#1242-1 
Alisporivir Novartis Roca and 
Ramakrishnan, 2013 
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Xestospongin C (XestC) Cambridge Bioscience Cat#64950-10 ug-
CAY 
Ryanodine Generon Cat#2489-500 
Dantrolene sodium salt Sigma-Aldrich Cat#D9175-1G; 
CAS: 14663-23-1 
Nifedipine Cambridge Bioscience Cat#N3228-1 g 
Diltiazem Cambridge Bioscience Cat#D3447-1 g 
Verapamil HCl Fisher Scientific Cat#10403045 
Thapsigargin Sigma-Aldrich Cat#T9033-.5MG; 
CAS: 67526-95-8 
4-Chloro-m-cresol (4CmC) Sigma-Aldrich Cat#55402-5G; 
CAS: 59-50-7 
MitoTracker Red CM-H2-Xros Fisher Scientific Cat# M7513 
MitoSOX Fisher Scientific Cat#M36008 
Desipramine hydrochloride Sigma-Aldrich Cat#D3900-5G; 
CAS: 58-28-6 
Necrostatin-1 Alfa Aesar Cat#J65341.F+; 
CAS: 4311-88-0 
Necrosulfonamide (NSA) Cambridge Bioscience Cat#20844-5mg-
CAY; 
CAS: 1360614-45-7 
PTU (1-phenyl-2-thiourea) Sigma-Aldrich Cat#P7629; 
CAS: 103-85-5 
Tango Buffer (10x) Thermo Scientific Cat#BY5 
PMA (Phorbol 12-myristate 13-acetate) Sigma-Aldrich Cat#P1585-1MG; 
CAS: 16561-29-8 
Human recombinant TNF Sigma-Aldrich Cat#SRP3177-50UG 
D (+) Trehalose dehydrate Sigma-Aldrich Cat#T0167-10G 
Nec-1s Cambridge Bioscience Cat#2263-5 
Q-VD-OPh Source Bioscience Cat#ABE283 
Z-VAD-FMK Cambridge Bioscience Cat#14463-1MG-
CAY 
SYTOX® Green Nucleic Acid Stain Life Technologies Cat#S7020 
   
Critical Commercial Assays 
Gibson Assembly 
NEBuilder HiFi DNA Assembly Master Mix New England Biolabs Cat#E2621 
RNeasy Mini Kit Qiagen Cat#74104 
mMessage mMachine kit Ambion  
polyA Tailing kit Ambion  
   
Deposited Data 
   
Experimental Models: Cell Lines 
THP-1 human monocytic cell line ATCC TIB-202 
 
Experimental Models: Organisms/Strains 
Zebrafish (Danio rerio): wild type AB strain University of 
Cambridge 
ZFIN ID: ZDB-
GENO-960809-7 
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Zebrafish: Tg(mpeg1:YFP)w200 (Roca and 
Ramakrishnan, 2013) 
ZFIN ID: ZDB-FISH-
150901-6828 
Zebrafish: Tg(mpeg1:Brainbow)w201 (Pagan et al., 2015) ZFIN ID: ZDB-FISH-
151204-7 
Zebrafish: baxarr1 This work  
Zebrafish: baxbrr10 This work  
Zebrafish: ripk3rr7 This work  
Zebrafish: Tg(BH:GFP-mfap4:Mito-GCaMP3) This work  
   
Oligonucleotides 
Morpholino: Cathepsin D E2/I2 
TGTCAGCAAGCAGATACTCACATCT 
Gene Tools 
(Follo et al., 2011) 
ZDB-MRPHLNO-
110722-2 
Morpholino: BID GGTCAAAGTTCCTGTTGAAGTCCAT Gene Tools 
(Kratz et al., 2006) 
ZDB-MRPHLNO-
070126-2 
Morpholino: PGAM5 AGCGCCCTCCGAAAAGACATGCTTC (Roca and 
Ramakrishnan, 2013) 
ZDB-MRPHLNO-
130820-4 
Morpholino: cyclophilin D-ATG 
TTGGGTTTGACATTTTCTTAGAT 
Gene Tools 
(Roca and 
Ramakrishnan, 2013) 
ZDB-MRPHLNO-
130820-5 
Baxarr1 forward primer for genotyping by HRM, 
sequence: 5’-GACCTCTGCCTCTTGCAGCTT-3’ 
This work N/A 
Baxarr1 reverse primer for genotyping by HRM, 
sequence: 5′-GCAAACACTGCGCGAGGCGTT-3′ 
This work N/A 
Baxbrr10 forward primer for genotyping by HRM, 
sequence: 5′-GTTGCATCAAGTTTATGAGGTGTTG-3′ 
This work N/A 
Baxbrr10 reverse primer for genotyping by HRM, 
sequence: 5′-CAGGGTAGTAAGGCAGGAGCTAATGG-3′ 
This work N/A 
RIPK3rr7 forward primer for genotyping by HRM, 
sequence: 5′-AGAGAAGCGGAGCTGATGTTTGAT-3′ 
This work N/A 
RIPK3rr7 reverse primer for genotyping by HRM, 
sequence: 5′-CTTGGCATCCAGGCTGTCACTCAGC-3′ 
This work N/A 
   
Recombinant DNA 
Zebrafish full length BAX This work N/A 
Zebrafish BH3-BAX This work N/A 
Zebrafish MOM-BH3-BAX This work N/A 
Zebrafish ER-BH3-BAX This work N/A 
Zebrafish MOM-full length BAX This work N/A 
Zebrafish TMBIM3 This work N/A 
Zebrafish TMBIM6 This work N/A 
Venus-V2A-BH4 (from BC-L2) This work N/A 
pTol2-PhiC31LS-BH:GFP-mfap4:Mito-GCaMP3 This work N/A 
pME mitoGCaMP3 D. Raible Laboratory 
(Esterberg et al., 
2014) 
N/A 
pTol2 PhiC31LS BH NewMCS (cmlc2:eGFP) This work N/A 
pTol2 PhiC31LS BH NewMCS (cmlc2:RFP) This work N/A 
pTol2 mfap4:TdTomato-CAAX D. Tobin Laboratory 
(Walton et al., 2015) 
N/A 
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pSB_PhiC31LandingSite (Kirchmaier et al., 
2013) 
Addgene #48875 
pCS2P+ Marc Kirschner Addgene #17095 
   
Software and Algorithms 
NIS-Elements Nikon N/A 
Imaris Bitplane N/A 
Prism GraphPad N/A 
ImageJ (Abramoff et al., 2004) N/A 
FPC (ImageJ); macro for quantification of bacterial 
burden by fluorescence imaging used in this work for 
quantification of camptothecin-induced apoptosis 
(Takaki et al., 2013) N/A 
CorelDraw X5 Corel N/A 
   
Other: 
Gene Symbols and names used for Zebrafish mutant and overexpression lines 
(Gene abbreviations follow Zebrafish Nomenclature Guidelines 
(https://wiki.zfin.org/display/general/ZFIN+Zebrafish+Nomenclature+Conventions)  
Gene symbol Name used  
baxa BAXA/BAX  
baxb BAXB  
ctsd Cathepsin D (catD)  
bida BID  
pgam5 PGAM5  
ppid Cyclophilin D 
(CYPD) 
 
smpd1 aSM  
grinab TMBIM3  
tegt TMBIM6  
bcl2a BC-L2  
ryr RyR  
itpr IP3R  
ripk1l RIPK1  
ripk3l RIPK3  
lta4h LTA4H  
 
 
 
  
 30 
FIGURE LEGENDS 
Figure 1: Ceramide causes necrosis through Cathepsin D, BID and BAX. 
(A) Cartoon of TNF-mediated necrosis pathway components. CYPD, cyclophilin D; M, 
mitochondrion; L, lysosome. 
(B) Confocal images of granulomas in 3 or 5 dpi TNF-high or control larvae with yellow 
fluorescent macrophages infected with red fluorescent Mm. Arrowheads, extracellular bacteria; 
arrows, extracellular, cording bacteria. Scale bar 100 μm.   
(C) Cording in 5 dpi TNF-high and control larvae 
(D) Cording in 5 dpi TNF-high or control larvae treated with Pepstatin A.  
(E) Cording in 5 dpi TNF-high or control larvae treated with E64d.  
(F) Cording in 5 dpi TNF-high and control larvae that are WT or Cathepsin D morphant.  
(G) Cording in 5 dpi TNF-high and control larvae that are WT or BID morphant.  
(H) Cording in 5dpi TNF-high and control larvae treated with BI-6C9. 
(I) Cording in 5 dpi TNF-high or control larvae that are WT or BAXA mutant.  
(J) Cording in 5 dpi TNF-high and control larvae that are WT or BAXB mutant.  
(C) to (J): *p < 0.05; **p < 0.01; ***p < 0.001 (Fisher’s exact test). Each panel representative of 
3 - 6 independent experiments. 
See also Figure S1. 
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Figure 2: BAX mediates macrophage necrosis by promoting mitochondrial Ca2+ overload 
independent of BH3-dependent oligomerization and interaction with the mitochondrial 
outer membrane.  
(A) Schematic of BAX to show BH domains. 
(B) Cording in 5 dpi TNF-high and control larvae that are WT, BAX mutant or BAX mutant 
expressing BH3-BAX. ***p < 0.001 (Fisher’s exact test). Representative of 6 independent 
experiments. 
(C) Cording in 5 dpi TNF-high and control larvae treated with BAX channel blocker (BCB). 
***p < 0.001 (Fisher’s exact test). Representative of 3 independent experiments. 
(D) Cording in 5 dpi TNF-high and control larvae that are WT, BAX mutant, BAX mutant 
expressing BH3-BAX or BAX mutant expressing BH3-BAX targeted to the mitochondrial 
outer membrane (MOM-BH3-BAX). *p < 0.05; **p < 0.01 (Fisher’s exact test). Representative 
of 2 independent experiments. 
(E) Representative confocal images of 1 dpi TNF-high (90 minutes post-TNF treatment) or 
control larvae, both expressing mitGCaMP3 (GCaMP3 targeted to the mitochondria) in their 
macrophages, which are red fluorescent. Area shown corresponds to area in the shaded rectangle 
in the cartoon above. Detailed image of orange rectangle in TNF-high larva additionally shows 
the bacteria within a mitGCaMP3-expressing macrophage. Scale bars 10 μm. 
(F) Quantitation of mitGCaMP3 fluorescence in individual macrophages from larvae in (A). 
Black and red symbols represent uninfected and Mm-infected macrophages, respectively, in the 
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same control or TNF-treated animal. Horizontal bars, means; ***p < 0.001 (one-way ANOVA 
with Tukey’s post-test). Representative of 2 independent experiments. 
(G) Representative confocal images of 1 dpi TNF-high (120 minutes post-TNF treatment) or 
control larvae with yellow fluorescent macrophages showing Rhod-2 fluorescence (red). Area 
shown similar to (A). Detail: macrophage in the orange rectangle. Scale bar 10 μm. 
(H) Percentage of uninfected or Mm-infected macrophages with Rhod-2 fluorescence from TNF-
high larvae in (C). Black and red symbols represent uninfected and Mm-infected macrophages, 
respectively, in the same control or TNF-treated animal. Horizontal bars, means; ***p < 0.001 
(one-way ANOVA with Tukey’s post-test). Representative of 2 independent experiments. 
(I) Time lapse confocal images of two infected macrophages in a 1 dpi larva at indicated time 
points after TNF administration. Arrowhead, Rhod-2 positive macrophage; asterisk, dead 
macrophage; arrow, extracellular bacteria. Scale bar 10 μm. 
See also Figure S2. 
 
Figure 3. BAX promotes Ca2+ flow from the ER into the mitochondrion. 
(A) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae treated 
with Ru360. Horizontal bars, means; **p < 0.01; ***p < 0.001 (one-way ANOVA with Tukey’s 
post-test). Representative of 2 independent experiments. 
(B) Cording in 5dpi TNF-high and control larvae treated with Ru360. *p < 0.05 (Fisher’s exact 
test). Representative of 5 independent experiments. 
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(C) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae that are 
WT or BAX mutant. Horizontal bars, means; ***p < 0.001 (one-way ANOVA with Tukey’s 
post-test). Representative of 2 independent experiments. 
(D) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae treated 
with desipramine. Horizontal bars, means; *p < 0.05 (one-way ANOVA with Tukey’s post-test).   
(E) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae that are 
WT, Cathepsin D or BID morphant. Horizontal bars, means; ***p < 0.001 (one-way ANOVA 
with Tukey’s post-test). Representative of 2 independent experiments. 
(F) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae that are 
WT, BAX mutant, or BAX mutant expressing BH3-BAX, MOM- or ER-targeted BH3-BAX. 
Horizontal bars, means; ***p < 0.001 (one-way ANOVA with Tukey’s post-test). Representative 
of 2 independent experiments. 
(G) Cording in 5dpi TNF-high or control larvae that are WT, BAX mutant, BAX mutant 
expressing BH3-BAX or BAX mutant expressing ER-targeted BH3-BAX. **p < 0.01 
(Fisher’s exact test). Representative of 2 independent experiments. 
(H) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae treated 
with thapsigargin. Horizontal bars, means; ***p < 0.001 (one-way ANOVA with Tukey’s post-
test). 
(I) Cording in 5 dpi TNF-high or control larvae treated thapsigargin. *p < 0.05; **p < 0.01 
(Fisher’s exact test). Representative of 3 independent experiments. 
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(J) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae that are WT 
or overexpressing TMBIM3 or TMBIM6. Horizontal bars, means; ***p < 0.001 (one-way 
ANOVA with Tukey’s post-test). Representative of 2 independent experiments. 
(K) Cording in 5 dpi TNF-high or control larvae that are WT or overexpressing TMBIM3 or 
TMBIM6. *p < 0.05; **p < 0.01 (Fisher’s exact test). Representative of 2 independent 
experiments. 
 
Figure 4. Ryanodine receptor mediates macrophage necrosis in excess TNF conditions 
(A) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae that are 
WT or expressing the BH4 domain of BCL-2 or BCL-XL. Horizontal bars, means; ***p < 0.001 
(one-way ANOVA with Tukey’s post-test). 
(B) Cording in 5dpi TNF-high and control larvae that are WT or expressing the BH4 domain of 
BCL-2. *p < 0.05; **p < 0.01 (Fisher’s exact test). Representative of 3 independent experiments. 
(C) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae treated 
with Xestospongin C or Ryanodine. Horizontal bars, means; ***p < 0.001 (one-way ANOVA 
with Tukey’s post-test). Representative of 2 independent experiments. 
(D) Cording in 5dpi TNF-high and control larvae treated with Xestospongin C or Ryanodine. 
**p < 0.01; ***p < 0.001 (Fisher’s exact test). Representative of 2 independent experiments. 
(E) Percentage of larvae with cording among WT or siblings expressing the BH4 domain of 
BCL-XL injected with TNF. *p < 0.05; ***p < 0.001 (Fisher’s exact test). Representative of 2 
independent experiments. 
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(F) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae treated with 
dantrolene. Horizontal bars, means; **p < 0.01; ***p < 0.001 (one-way ANOVA with Tukey’s 
post-test). 
(G) Cording in 5dpi TNF-high and control larvae treated with dantrolene. ***p < 0.001 (Fisher’s 
exact test). Representative of 4 independent experiments. 
(H) Representative confocal images of 3 day larvae expressing GCaMP3 targeted to the 
mitochondria of their macrophages which are red fluorescent, 2 hours after administration of 
4CmC. larvae. Scale bar 10 μm. 
(I) Cording in 5dpi TNF-high and control larvae that are WT or BAX mutant and treated with 
Ru360 and/or 4CmC. *p < 0.05 (Fisher’s exact test). Representative of 2 independent 
experiments. 
See also Table S1. 
 
Figure 5. Mitochondrial ROS launch the pathogenic mitochondrial - lysosomal - ER circuit 
that leads to mitochondrial Ca2+ overload and macrophage necrosis. 
(A) Time lapse confocal images of an infected macrophage in a 1 dpi mitGCaMP3 larva at 
indicated time points after TNF administration with MitoTracker Red CM-H2Xros. Scale bar 5 
μm. 
(B) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae treated 
with NAC, GSH, MitoTEMPO or amifostine. Horizontal bars, means; ***p < 0.001 (one-way 
ANOVA with Tukey’s post-test). 
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(C) Quantification of mitochondrial ROS production in 1 dpi TNF-high or control larvae that are 
WT, WT treated with necrostatin-1, PGAM5 morphant or RIPK3 mutant. Horizontal bars, 
means; ***p < 0.001 (one-way ANOVA with Tukey’s post-test).  
(D) Percentage of Rhod-2-positive macrophages in 1dpi control and TNF-high larvae control, 
that are WT, WT treated with necrostatin-1, PGAM5 morphant or RIPK3 mutant. Horizontal 
bars, means; ***p < 0.001 (one-way ANOVA with Tukey’s post-test).  
(E) Quantification of mitochondrial ROS production in 1 dpi TNF-high or control larvae that are 
WT, WT treated with desipramine or Cathepsin D morphant. Horizontal bars, means; ***p < 
0.001 (one-way ANOVA with Tukey’s post-test).  
(F) Quantification of mitochondrial ROS production in 1 dpi TNF-high or control larvae that are 
WT, WT treated with dantrolene, BID morphant or BAX mutant. Horizontal bars, means; *p < 
0.05; **p < 0.01 (one-way ANOVA with Tukey’s post-test). 
(G) Quantification of mitochondrial ROS production in 1 dpi TNF-high or control larvae that are 
WT, WT treated with alisporivir, or cyclophilin D morphant. Horizontal bars, means; *p < 0.05; 
**p < 0.01 (one-way ANOVA with Tukey’s post-test). 
(H) Percentage of Rhod-2-positive macrophages in 1 dpi TNF-high or control larvae that are 
WT, WT treated with alisporivir, or cyclophilin D morphant. Horizontal bars, means; ***p < 
0.001 (Fisher’s exact test). 
(I) Cording in 5 dpi TNF-high or control larvae that are WT, WT treated with alisporivir, or 
cyclophilin D morphant. **p < 0.01; ***p < 0.001 (Fisher’s exact test). 
See also Figure S3. 
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Figure 6. Pharmacological inhibition of voltage-gated L-Type Calcium channels inhibits 
TNF-mediated macrophage mitochondrial Ca2+ overload and necrosis in Mm- and Mtb-
infected larvae. 
(A) Percentage of Rhod-2-positive macrophages in 1 dpi control or TNF-high larvae treated with 
nifedipine, verapamil or diltiazem. Horizontal bars, means; **p < 0.01; ***p < 0.001 (one-way 
ANOVA with Tukey’s post-test). Representative of 2 independent experiments. 
(B-D) Cording in 5 dpi control or TNF-high larvae treated with nifedipine (B), diltiazem (C) and 
verapamil (D). *p < 0.05; **p < 0.01; ***p < 0.001 (Fisher’s exact test). Representative of 2-4 
independent experiments. 
(E) Representative confocal images of 1 dpi larvae with yellow fluorescent macrophages infected 
with 100 WT Mm or 80 Mtb (both red fluorescent). Scale bar 50 μm. 
(F) Quantitation of mitochondrial ROS production in infected macrophages of 1 dpi TNF-high or 
control larvae infected with 100 WT Mm or 80 Mtb. Horizontal bars, means; ***p < 0.001 (one-
way ANOVA with Tukey’s post-test). 
(G) Quantitation of mitGCaMP3 fluorescence in infected macrophages in 1 dpi TNF-high or 
control larvae infected with 100 WT Mm or 185-200 Mtb treated with dantrolene, nifedipine, 
diltiazem or verapamil. Horizontal bars, means; ***p < 0.001 (one-way ANOVA with Tukey’s 
post-test). 
 
Figure 7. Mycobacterium-infected human macrophages undergo TNF-mediated necrosis. 
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(A) Model of TNF-mediated macrophage necrosis pathway. LMP, lysosomal membrane 
permeabilization; previously identified drugs in green, drugs identified in this study in blue. 
(B) THP-1 macrophage death 5 h after TNF administration (Mean + SD). CON, macrophages 
from uninfected wells; INF, Mm-infected macrophages in infected wells; UNINF, uninfected 
macrophages in infected wells.  
(C) Quantification of TNF-induced macrophage death in multiple experiments. Column 1: Ratio 
of TNF-treated to vehicle-treated dead Mm-infected macrophages. Column 2: Ratio of dead 
infected macrophages to dead uninfected macrophages in the same TNF-treated well. Column 3: 
Ratio of dead macrophages in TNF-treated to vehicle-treated uninfected wells . Mean + SEM of 
12 independent experiments for columns 1 and 2, and 11 independent experiments for column 3; 
one sample t test to a hypothetical value of 1, corresponding to the null hypothesis that TNF and 
infection do not influence cell death.  
(D) Percentage of dead Mm-infected macrophages after TNF administration treated with 
necrostatin-1 or Nec-1s. Horizontal bars, means. Representative of 3 independent experiments. 
(E) Percentage of dead Mm-infected macrophages after TNF administration treated with 
necrostatin-1, Q-VD-OPh, or Z-VAD-FMK. Horizontal bars, means. Representative of 3 
(necrostatin-1 and Z-VAD-FMK) or 2 (Q-VD-OPh) independent experiments. 
(F-G) Percentage of dead Mm-infected macrophages after TNF administration treated with BI-
6C9, dantrolene, Ru360 (E) and diltiazem, nifedipine or verapamil (F). Horizontal bars, means; 
*p <0.05; **p<0.01; ***p<0.001 (one-way ANOVA with Bonferroni’s post-test for comparisons 
shown). 
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(H) Percentage of dead Mtb-infected macrophages after TNF administration treated with 
dantrolene, diltiazem, nifedipine or verapamil. Horizontal bars, means; ****p<0.0001 (one-way 
ANOVA with Bonferroni’s post-test for comparisons shown).  
See also Figure S4 and Tables S1 and S2.  
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SUPPLEMENTAL FIGURE TITLES AND LEGENDS 
Supplemental Figure 1 (related to Figure 1). Camptothecin-induced apoptosis is decreased 
in BAXA and BAXB mutant zebrafish. 
(A) Global analysis without end-gap penalty of protein sequence homology between human 
BAK1 (transcripts 202 and 203), BAX (only major transcripts, alpha and beta) and zebrafish 
BAXA and BAXB. Prefix h, human; prefix zf, zebrafish.  Although BAXB has been suggested 
to be the zebrafish functional equivalent of human BAK (Kratz et al., 2006), neither it nor 
BAXA had significant homology to either human BAK transcript. Identity (red) (%), similarity 
(%), (global/local score). 
(B) Comparison of protein sequence homology between human BAX alpha and zebrafish 
BAXA. Relevant BH domains of BAX are showed in colored boxes. 
(C) Representative inverted fluorescence images of 2 dpf larvae that are WT, BAXA mutant or 
BAXB mutant treated with camptothecin and incubated with acridine orange to detect apoptotic 
cells. 
(D) Quantification of camptothecin-induced apoptosis (See Experimental Procedures) in WT, 
BAXA mutant or BAXB mutant fish from (C) in the area within red dashed line. *p < 0.05; **p 
< 0.01; ***p < 0.001 (one-way ANOVA with Tukey’s post-test). Representative of 3 
independent experiments. 
 
Supplemental Figure 2 (related to Figure 2). BH3 domain of BAX is required for apoptosis   
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(A) Percentage survival of 5 and 24 hpf BAX mutant larvae expressing WT BAX or BH3-
BAX. ***p < 0.001 (one-way ANOVA with Tukey’s post-test). Mean of 3 experiments (±SEM) 
is represented. 
(B) Quantification of camptothecin-induced apoptosis in 2 dpf larvae that are WT, BAXA 
mutant or BAXA mutant expressing BH3-BAX. Horizontal bars, means; *p < 0.05; ***p < 
0.001 (one-way ANOVA with Tukey’s post-test). Representative of 2 independent experiments. 
(C) Quantification of camptothecin-induced apoptosis in 2 dpf larvae treated with BCB. 
Horizontal bars, means; **p < 0.01; ***p < 0.001 (one-way ANOVA with Tukey’s post-test). 
Representative of 2 independent experiments.   
(D) Percentage survival of 5 and 24 hpf BAX mutant larvae expressing MOM-WT or MOM-
BH3-BAX. BAX mutant embryos expressing MOM-WT BAX shows similar mortality to those 
expressing untagged WT BAX from panel A ***p < 0.001 (one-way ANOVA with Tukey’s 
post-test). Mean of 3 experiments (±SEM) is represented. 
 
Supplemental Figure 3 (related to Figure 5). TNF triggers mitochondrial ROS production 
only in infected macrophages. 
(A) Representative confocal images of 1 dpi TNF-high or control larvae with yellow fluorescent 
macrophages, showing MitoTracker Red CM-H2Xros fluorescence corresponding to similar area 
of the fish as in Figure 3 (A). Detail: macrophage in the orange rectangle. Scale bar 10 μm. 
(B) Quantification of mitochondrial ROS production in 1 dpi TNF-high or control larvae. Each 
point represents the mean of maximum intensity fluorescence of MitoTracker Red CM-H2Xros 
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per fish from images in (A). Black and red symbols represent uninfected and Mm-infected 
macrophages, respectively, in the same control or TNF-administered animal. Horizontal bars, 
means; ***p < 0.001 (one-way ANOVA with Tukey’s post-test).  
(C) Representative confocal images of 1 dpi TNF-high or control larvae showing MitoSOX 
fluorescence (red) corresponding to similar area of the fish as in Figure 3 (A). Detail: 
macrophage in the orange rectangle. Scale bar 10 μm. 
(D) Quantification of mitochondrial ROS production in 1 dpi TNF-high or control larvae. Each 
point represents the mean of maximum intensity fluorescence of MitoSOX per fish from images 
in (C). Black and red symbols represent uninfected and Mm-infected macrophages, respectively, 
in the same control or TNF-administered animal. Horizontal bars, means; ***p < 0.001 (one-way 
ANOVA with Tukey’s post-test). 
 
Supplemental Figure 4 (related to Figure 7). Treatment with inhibitors of the TNF-
mediated necrosis pathway in the presence of TNF does not influence death of uninfected 
macrophages. 
(A) Percentage of dead Mm-infected (filled symbols) or uninfected macrophages after TNF 
administration treated with necrostatin-1 or nec-1s. Horizontal bars, means. 
(B) Percentage of dead Mm-infected (filled symbols) or uninfected macrophages after TNF 
administration treated with necrostatin-1, Q-VD-OPh, or Z-VAD-FMK. Representative of 3 
(necrostatin-1 and Z-VAD-FMK) or 2 (Q-VD-OPh) independent experiments. Horizontal bars, 
means. 
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(C) Percentage of dead Mm-infected (filled symbols) or uninfected macrophages after TNF 
administration treated with BI-6C9, dantrolene or Ru360.  Horizontal bars, means. 
(D) Percentage of dead Mm-infected (filled symbols) or uninfected macrophages after TNF 
administration treated with diltiazem, nifedipine or verapamil. Horizontal bars, means. 
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STAR METHODS 
CONTACT FOR REAGENT AND RESOURCE SHARING 
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Lalita Ramakrishnan (lr404@cam.ac.uk). 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Zebrafish husbandry and infections 
Zebrafish husbandry and experiments were conducted in compliance with guidelines from the 
UK Home Office (experiments conducted in the University of Cambridge) and with the U.S. 
Public Health Service Policy on Humane Care and Use of Laboratory Larvae using protocols 
approved by the Institutional Animal Care and Use Committee of the University of Washington 
(generation of Baxarr1 and Baxbrr10 mutant lines in the University of Washington). Zebrafish AB 
wild-type strain (Zebrafish International Resource Center) and transgenic or mutant lines in the 
AB background were used, including Tg(mpeg1:YFP)w200 (with yellow fluorescent macrophages) 
(Roca and Ramakrishnan, 2013), Tg(mpeg1:Brainbow)w201 (with red fluorescent macrophages) 
(Pagan et al., 2015), Tg(BH:GFP-mfap4:Mito-GCaMP3) (expressing the genetically Ca2+ sensor 
targeted to the mitochondrion in macrophages) (this work), baxarr1 (this work), baxbrr10 (this 
work) and ripk3rr7 (this work). All zebrafish lines were maintained in buffered reverse osmotic 
water systems and were exposed to a 14 hr light - 10 hr dark cycle to maintain proper circadian 
conditions. Fish were fed twice daily a combination of dry food and brine shrimp. Zebrafish 
embryos were housed in fish water (reverse osmosis water containing 0.18 g/l Instant Ocean) at 
28.5°C. Embryos were maintained in 0.25 g/ml methylene blue from collection to 1 day post-
fertilization (dpf). 0.003% PTU (1-phenyl-2-thiourea, Sigma) was added from 24 hours post-
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fertilization (hpf) on to prevent pigmentation. Larvae (of undetermined sex given the early 
developmental stages used) were anesthetized in fish water containing 0.025% tricaine (Sigma) 
and infected at 48 hpf via caudal vein (CV) injection using single-cell suspensions of Mm or Mtb 
of known titer (Takaki et al., 2012; Takaki et al., 2013). Larvae were randomly allotted to the 
different experimental conditions. Number of larvae to be used for each experiment was guided 
by pilot experiments to reach statistical significance and each experiment was repeated two or 
more times.  
Generation of the transgenic zebrafish line Tg(BH:GFP-mfap4:Mito-GCaMP3): the plasmid 
pTol2-PhiC31LS-BH:GFP-mfap4:Mito-GCaMP3 was generated by PCR amplifying the mito-
GCaMP3 cassette from the plasmid pME mitoGCaMP3 (Esterberg et al., 2014) and cloning into 
a Tol2 plasmid with a green bleeding heart cassette (cmlc2:eGFP) for screening [pTol2 
PhiC31LS BH NewMCS (cmlc2:eGFP)] followed by cloning of the mfap4 promoter (Walton et 
al., 2015). The plasmid pTol2-PhiC31LS-BH NewMCS (cmlc2:RFP) was generated by 
NEBuilder HiFi DNA Assembly following the manufacturer protocol by combining the 
backbone of the Tol2 plasmid pTol2 mfap4:TdTomato-CAAX (Walton et al., 2015) with 
sequence containing the bleeding heart and Phi31 Landing cassettes from the plasmid 
pSB_PhiC31LandingSite (Kirchmaier et al., 2013) (Addgene plasmid 48875) where HA tag was 
previously removed and a new multi-cloning site inserted. A version of pTol2 PhiC31LS BH 
NewMCS with eGFP expression in the myocardium [pTol2 PhiC31LS BH NewMCS 
(cmlc2:eGFP)] was generated by replacing RFP with eGFP by NEBuilder HiFi DNA Assembly. 
The pTol2-PhiC31LS-BH:GFP-mfap4:Mito-GCaMP3 plasmid was injected along with 
transposase mRNA into one- to two-cell-stage embryos of the wild-type AB strain as previously 
described (Suster et al., 2011) using injection mix (1× Tango Buffer (Thermo Scientific) 
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containing 2% phenol red sodium salt solution (Sigma)). Putative founders were identified by 
GFP expression in the heart and crossed to wild-type AB zebrafish. Transgenic lines were 
identified in the next generation and kept on the AB strain.  
BAXA-, BAXB and RIPK3-deficient zebrafish lines were generated by using the CRISPR/Cas9 
system (Irion et al., 2014) at the University of Washington. The mutation consists of a single 
nucleotide (G) deletion in exon 3 of baxa, a deletion of three nucleotides (TGG) and insertion of 
thirteen nucleotides (AATAAAGAGGTGA) in exon 3 of baxb and a deletion of eleven 
nucleotides (TCTGCTGCAGA) and insertion of eighteen nucleotides 
(GAACGTTTTTAGAAAGCA) in exon 2 of RIPK3. All these mutations result in a frame shift 
and multiple premature STOP codons. baxarr1, baxbrr10 and ripk3rr7 lines were genotyped by 
high-resolution melt analysis (HRMA) (Garritano et al., 2009) of PCR products (see Key 
Resources Table for sequences) on a CFX Connect thermocycler (BioRad).  
THP-1 cell culture and differentiation into macrophages 
THP-1 cells (ATCC TIB-202) were maintained in RPMI 1640 culture media supplemented with 
10% fetal bovine serum (FBS, GIBCO) and 1% L-glutamine (Sigma). THP-1 cells were 
differentiated into macrophages by stimulation with 200 nM phorbol 12-myristate 13-acetate 
(PMA) (Sigma) in 24 well black optical bottom plates (Perkin Elmer), at a density of 3 x 105 
macrophages per well. On day 3 post differentiation, the resulting adherent cells were washed 
with fresh medium and incubated for 3-5 days before infection (protocol modified from 
(Daigneault et al., 2010)).  
METHOD DETAILS 
Bacterial strains 
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WT M. marinum M strains (ATCC #BAA-535) expressing tdTomato, tdKatushka, or EBFP2 
under the msp12 promoter (Takaki et al., 2013) were grown under hygromycin B (Formedium) 
selection in 7H9 Middlebrook medium (Difco) supplemented with oleic acid, albumin, dextrose, 
and Tween-80 (Sigma) (Takaki et al., 2013). 
M. tuberculosis ΔleuD ΔpanCD double auxotroph expressing mCherry or GFP under control of 
the msp12 promoter were grown under hygromycin B (Formedium) and kanamycin selection in 
Middlebrook 7H9 broth (Difco) supplemented with oleic acid, albumin, dextrose, catalase, 
Tween-80 (Sigma), 0.05 mg/ml L-leucine and 0.024 mg/ml calcium pantothenate (Sigma) 
(Sampson et al., 2011). 
TNF and drug administration to zebrafish larvae  
0.5 ng of recombinant zebrafish soluble TNF (Roca et al., 2008) or vehicle were microinjected 
into the caudal vein of each animal 1 day post infection to create TNF-high animals (Tobin et al., 
2012). To assess drug treatment in infected fish, equivalently-infected sibling larvae were mixed 
in a petri dish and held at 28.5°C until they were then randomly allocated to the drug-treated or 
control. DMSO (Sigma) was kept at 0.5% in all conditions when drugs were being used. All 
drugs were dissolved in DMSO (Sigma) or water and kept in small aliquots at -20°C. The 
rationale for the doses used in this work was based on previous studies or pilot experiments, 
using the minimum effective concentration. None of these concentrations showed toxic effects in 
the larvae at the end of the experiment. All drugs were administered by adding them to the fish 
water. BI-6C9 (5 M) (Sigma), BCB (Bax Channel Blocker) (10 M) (Alfa Aesar) and 
alisporivir (10 M) (Novartis) were administered 4 hours after infection and removed 24 hours 
post TNF administration. Pepstatin A (7.5 M) (Sigma), E64d (1 g/ml) (Sigma), Ru360 (2 M) 
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(VWR International), thapsigargin (1.5 M) (Sigma), desipramine (10 M) (Sigma), necrostatin-
1 (10 M) (Alfa Aesar), amifostine (40 M) (Cambridge Bioscience), NAC (30 M) 
(Cambridge Bioscience), mitotempo (20 M) (Cambridge Bioscience), GSH (20 M) 
(Cambridge Bioscience), xestospongin C (5 M) (Cambridge Bioscience), ryanodine (2 M) 
(Generon), dantrolene (5 M) (Sigma), 4-Chloro-m-cresol (4CmC) (10 M) (Sigma), nifedipine 
(dihydropyridine) (3 M) (Cambridge Bioscience), diltiazem (benzothiazepine) (5 M) 
(Cambridge Bioscience) and verapamil (phenylalkylamine) (10 M) (Fischer Scientific) were 
administered 5 hours prior and removed 24 hours post TNF administration. For experiments 
quantifying mitochondrial ROS production or mitochondrial Ca2+ overload, drugs were 
administered 4 hours after infection or 5 hours prior to TNF administration as detailed before and 
maintained during imaging. 
Morpholino knockdown 
Cathepsin D-splice-blocking and BID-, cyclophilin D- and PGAM5-translation-blocking 
morpholinos (see Key Resources Table for sequences) (Gene Tools) were diluted in injection 
solution and approximately 2-4 nl were injected into the yolk of one- to two-cell-stage embryos 
(Tobin et al., 2012). The concentration in the injection solution for each morpholino was 0.2 mM 
for Cathepsin D and 0.15 mM for BID, cyclophilin D and PGAM5.  
Synthetic mRNA synthesis and microinjection 
The sequences for the ORFs for acid ceramidase, BAXA, BC-L2 and TMBIM3 and 6 were 
obtained by PCR from zebrafish cDNA. The ORF for acid ceramidase was then cloned into the 
plasmid pCS2P+ and mRNA was generated with T7 (Roca and Ramakrishnan, 2013). The T7 
promoter followed by the Kozac sequence 5’-GCCGCCACC-3’ were inserted before the start 
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codon by PCR for all versions of BAXA, Venus-2A-BH4 (from BC-L2) and TMBIM3 and 6. 
BH3-BAX was generated by PCR by removing the BH3 domain. MOM-BAX and MOM-
BH3-BAX were generated by PCR by removing the Stop codon of BAX and fusing a linker 
sequence G4SG4SG4 followed by the MOM-targeting sequence from the protein ActA from 
Listeria monocytogenes (Zhu et al., 1996) and a Stop codon using as a template full length or 
BH3-BAX, respectively. ER-BH3-BAX was generated by PCR by removing the Stop codon 
of BAX and fusing the linker sequence G4SG4SG4 followed by the ER-targeting sequence from 
the rat protein cytochrome b5 (Zhu et al., 1996) and a Stop codon using as a template BH3-
BAX. Venus-2A-BH4 (from BC-L2) was generated by PCR. For larval survival experiments, the 
sequences for BAX and BH3-BAX were cloned in the plasmid pCS2P+ downstream and in 
frame with the sequence for venus-V2A to ensure expression of the constructs. RNA was 
synthesized using the mMessage mMachine kit (Ambion) and the polyA Tailing kit (Ambion). 2-
4 nl were injected into the yolk of one- to two-cell-stage embryos at different concentrations in 
injection solution.  
Zebrafish larvae microscopy  
Fluorescence microscopy was performed as described (Takaki et al., 2013). Quantification of 
camptothecin-induced apoptosis by acridine orange staining and assessments of mycobacterial 
cording were performed with a Nikon Eclipse Ti-E inverted microscope fitted with 4x and 10x 
objectives. For laser scanning confocal microscopy, anesthetized larvae were embedded in 1.5% 
low-melting-point agarose on optical bottom plates or dishes (MatTek Corporation). For long 
term microscopy, agarose was covered with fish water containing 0.007% Tricaine. A Nikon 
A1R confocal microscope with a 203 Plan Apo 0.75 NA objective was used to generate 35-40 
 50 
m z stacks consisting of 0.3-2 m optical sections. The galvano scanner was used for all static 
imaging and for time-lapse imaging of the CHT. Time-lapse images were taken at different 
intervals for up to 5 hr. Data were acquired with NIS Elements (Nikon). A heating chamber 
(Okolab) adapted to the microscope was used to maintain temperature constantly at 28.5°C 
during the imaging process. In Figure 1B a single z image is shown for the control panels to 
appreciate cellularity and maximum intensity projections for TNF-high panels to appreciate 
cording. Confocal images are pseudocolored to facilitate visualization. 
Embryo survival assay 
In vitro-transcribed mRNA’s for venus, venus-2A-baxa, venus-2A-BH3-baxa and venus-2A-
MOM-baxa were diluted in injecting solution and injected into the yolk of one- to two-cell-stage 
embryos (Tobin et al., 2012) at a concentration of 300ng/l. Embryo survival was monitored 5 
and 24 hours post injection.  
Assessment of camptothecin-induced apoptosis in whole zebrafish larvae 
2 dpf larvae were treated by bath with 500 nM camptothecin (Alfa Aesar) or DMSO (0.5% final 
concentration) and incubated for 6 hours at 28.5°C (Langheinrich et al., 2002). Then all larvae 
from each treatment were transferred to 1.5 ml centrifuge tubes containing 1 ml of fish water and 
2.4 g/ml acridine orange (Sigma) and incubated protected from the light with rotation at room 
temperature for 30 minutes (Paquet et al., 2009). Finally, larvae were washed twice in fish water 
with tricaine and acridine orange fluorescence was analyzed by microscopy as readout for 
apoptosis. ImageJ was used to quantify mean grey value for each animal as indicated in 
supplemental figure 1. 
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Mitochondrial Ca2+ overload detection and quantification assay in zebrafish larvae 
Mitochondrial Ca2+ overload was assayed by the increase in fluorescence intensity of the cell 
permeant mitochondrion-targeted Ca2+ indicator Rhod-2 AM (red fluorescence) (Pozzan and 
Rudolf, 2009) (Fisher Scientific) or the genetically encoded Ca2+ reporter GCaMP3 (green 
fluorescence) targeted to the mitochondrion [Tg(BH:GFP-mfap4:Mito-GCaMP3)]. 
Tg(mpeg1:YFP)w200 or Tg(mpeg1:Brainbow)w201; Tg(BH:GFP-mfap4:Mito-GCaMP3) larvae 
were infected with 90-120 EBFP2-expressing Mm or 185-200 GFP-expressing Mtb. To calculate 
the percentage of macrophages positive for Rhod-2, 1 day post infection (dpi) 
Tg(mpeg1:YFP)w200 larvae were microinjected via CV with a solution containing TNF and 31.25 
g/ml Rhod-2 or a solution containing vehicle for TNF and Rhod-2 only. 50 g Rhod-2 were 
diluted in 20 l DMSO and stored in 1 l aliquots at -20°C and protected from light. Then Rhod-
2 was diluted 1:40 in PBS and added 1:2 to the TNF solution. To quantify increased 
mitochondrial Ca2+ concentration, 1 dpi Tg(mpeg1:Brainbow)w201; Tg(BH:GFP-mfap4:Mito-
GCaMP3) larvae were microinjected via CV with TNF. After TNF or TNF and Rhod-2 
administration, larvae were prepared for time-lapse confocal imaging. Time-lapse images were 
taken at different intervals for 5 hr. Mitochondrial GCaMP3 fluorescence was quantified as 
maximum fluorescence intensity per macrophage for a single time point using NIS-Elements. 
Mitochondrial Ca2+ overload quantified as total Rhod-2 positive macrophages per animal in the 
area indicated in Figure 3A was determined over a period of 5 hours. When not otherwise stated 
in the figure legend, Rhod-2 positivity or mean of maximum mitoGCaMP3 fluorescence was 
quantified only in Mm- or Mtb-infected macrophages. 
Protein sequence analysis 
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LALIGN (Myers and Miller, CABIOS 1989) (https://embnet.vital-
it.ch/software/LALIGN_form.html) was used for global analysis without end-gap penalty of 
amino acid residue sequences. Percentage identity, percentage similarity and global/local score 
are shown in Table 1. Protein accession numbers: hBAX alpha (NM_138761.3), hBAX beta 
(NM_004324.3), hBAK1-202 (NM_001188.3), hBAK1-203 (ENST00000442998.6), zfBAXA 
(NM_131562), zfBAXB (NM_001013296). 
Mitochondrial ROS quantification assay in zebrafish larvae 
Mitochondrial ROS production was assayed by fluorescence intensity of two cell permeant 
fluorogenic probes for ROS which are targeted to the mitochondrion: MitoTracker Red CM-H2-
Xros (red fluorescence) (Roca and Ramakrishnan, 2013) (Fisher Scientific) and MitoSOX (red 
fluorescence) (Esterberg et al., 2014) (Fisher Scientific). MitoTracker Red CM-H2-Xros 
fluoresces red upon oxidation by diverse ROS while MitoSOX requires oxidation selectively by 
superoxide, the proximal reactive oxygen species produced by mitochondrial electron transport 
complexes  before becoming fluorescent after binding DNA (Murphy, 2009). 
Tg(mpeg1:YFP)w200 larvae were infected with 90-120 EBFP2-expressing WT Mm, Mm or 80 
GFP-expressing Mtb. Larvae were microinjected 1 dpi via CV with a solution containing TNF 
and 50 MitoTracker Red CM-H2-Xros or 68  MitoSOX or a solution containing vehicle 
for TNF and MitoTracker Red CM-H2-Xros or MitoSOX only. After TNF administration, larvae 
were prepared for confocal imaging and maintained within a heated incubation chamber (Oko-
labs) attached to the confocal. Time-lapse images were taken at different intervals for 2-3 hr 
starting 40-60 minutes after TNF administration. MitoTracker Red CM-H2-Xros or MitoSOX 
were diluted in DMSO and stored in 1 l 5 mM and 2.5 mM aliquots, respectively, at -20°C and 
protected from light. Then both probes were further diluted in PBS and added to the TNF 
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solution. Mitochondrial ROS production was quantified as MitoTracker Red CM-H2-Xros or 
MitoSOX maximum fluorescence intensity per macrophage using NIS-Elements. When not 
otherwise stated in the figure legend, mean of maximum MitoTracker Red CM-H2-Xros 
fluorescence was quantified only in Mm- or Mtb-infected macrophages. The use of the heating 
chamber allowed us to quantify mitochondrial ROS production under more physiological 
conditions: we had previously showed that ROS production occurred 3 hours post TNF 
administration (Roca and Ramakrishnan, 2013). Those results were obtained without a heating 
chamber, thus keeping larvae at the room temperature (around 20°C). By keeping the larvae at 
28.5°C we now show that mitochondrial ROS production occurs within an hour after TNF 
administration. 
THP-1 macrophage infection, TNF and drug administration and quantitation of cell death 
On day of infection, single cell suspensions of tdKatushka-expressing WT Mm or mCherry-
expressing M. tuberculosis ΔleuD ΔpanCD double auxotroph were diluted in RPMI 1640 
containing 10% FCS to a concentration of ~6 x 105 C.F.U. per ml, corresponding to an MOI of 1. 
Adherent differentiated THP-1-derived macrophages were incubated with mycobacteria-
containing medium or fresh medium for 3-4 hr at 33°C (Mm) or 37C (Mtb), then washed and 
incubated in fresh medium at 33°C (Mm) or 37°C (Mtb) overnight. The next day, human 
recombinant TNF (Sigma) in a solution of 5% trehalose/PBS (Sigma) was added to treatment 
wells for a final concentration of 10ng/ml and cells were then incubated for 5 hours. In 
experiments with small molecule inhibitors 10M Necrostatin-1, 10M Nec-1s (Cambridge 
Bioscience), 10M Q-VD-OPh (Source Bioscience), 10M Z-VAD-FMK (Cambridge 
Bioscience), 10M BI-6C9, 10M dantrolene and 2M Ru360), cells were pre-incubated with 
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drug or 0.1% DMSO vehicle control for 1 hr prior to TNF addition. In experiments with LTCC 
inhibitors (10M diltiazem, 5M nifedipine, and 5M verapamil), drug or 0.1% DMSO vehicle 
control were added immediately after Mm infection and incubated overnight before TNF 
addition. To identify necrotic cell death, SYTOX® Green Nucleic Acid Stain (Life 
Technologies), a green-fluorescent stain that is impermeant to live cells, was added to culture 
medium at least 30 minutes prior to imaging. Macrophages were imaged using a Nikon Ti-E 
inverted microscope fitted with 20x objective and 2-5 arbitrary images per well acquired with 
NIS Elements (Nikon). Cell necrosis was quantified by counting SYTOX® Green fluorescence-
positive infected and uninfected cells in each image using ImageJ or Imaris (Bitplane Scientific 
Software), and the total percentage per treatment well of SYTOX+ infected or SYTOX+ 
uninfected cells calculated by summing values obtained from all images per well. To calculate 
the ratios of Mm infected +TNF vs. infected –TNF, infected vs. uninfected dead within TNF-
treated wells, and control +TNF vs. control –TNF (Figure 8B), mean values were calculated for 
all conditions in each independent experiment (Table S3). 
QUANTIFICATION AND STATISTICAL ANALYSIS 
The following statistical analyses were performed using Prism 5.01 (GraphPad): One sample t-
test, one-way ANOVA with Bonferroni’s or Tukey’s post-test, Fisher’s exact test and Student’s 
unpaired t test. Error bars represent standard error of mean. Post-test P values are as follows:  
Not significant, * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. The statistical tests 
used for each figure can be found in the corresponding figure legend. Where the n value is given 
and not represented graphically in the figure, n represents the number of zebrafish used for each 
experimental group. 
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DATA AND SOFTWARE AVAILABILITY 
The following software was used: NIS-Elements (image acquisition in wide-field and confocal 
microscopy), Imaris (image analysis of macrophage death),  Corel Draw (figure preparation) and 
ImageJ (image analysis of macrophage death and quantification of camptothecin-induced 
apoptosis in zebrafish larvae); see Key Resources Table for more information. 
MATERIALS AND DATA AVAILABILITY 
Materials and Data will be made available upon request. 
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SUPPLEMENTAL DATA TITLES AND LEGENDS 
Table S1 (related to Figure 4 and Figure 7). Expression of ryanodine receptor isoforms in 
human macrophages and zebrafish blood monocytes. 
HUMAN ZEBRAFISH 
Homolog Expression Homolog 
Expression in 
blood mfap4+ 
cells (Athanasiadis 
et al., 2017) 
RyR1 
Macrophages: 
(EMBL-EBI expression atlas) 
THP1: 
Protein Atlas 
(https://www.proteinatlas.org) 
RyR1a Yes (high) 
RyR1b nd 
RyR2 
Lung macrophages 
(www.proteinatlas.org) 
RyR2a nd 
RyR2b Yes (high) 
RyR3 No data available RyR3 Yes (low) 
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Table S2 (related to Figure 7). THP-1 macrophage death (%) in all experiments. 
 
 
Experim
ent Code 
UNINF
ECTED 
WELL, 
NO 
TNF 
UNINF
ECTED 
WELL, 
+TNF 
UNINF
ECTED 
CELLS, 
NO 
TNF 
INFE
CTED 
CELL
S, NO 
TNF 
UNINF
ECTED 
CELLS, 
+TNF 
INFE
CTED 
CELL
S, 
+TNF 
 INF+T
NF/INF
-TNF 
INF+TNF/
Uninf+TNF 
within well 
ratio 
UNINF+TN
F/UNINF-
TNF (ALL 
UNINFEC
TED 
WELLS) 
INF-
TNF/ 
UNINF-
TNF 
within 
well 
ratio 
UNINF
+TNF/ 
UNINF
-TNF 
 J / 
L 
I/
M 
UWS00
3 
0.70 1.40 16.00 11.10 14.00 47.60   3.40  0.69     
 0.60 0.60 12.70 4.70 15.60 30.70   1.97  0.37     
mean 0.65 1.00 14.35 7.90 14.80 39.15  4.96 2.68 1.54 0.53 1.03  5.
0
5 
4.
8
1 
UWS00
4 
7.71 - 12.90 13.73 13.04 24.60     1.89   1.06         
 6.46 - 9.68 11.85 4.00 22.54   5.64  1.22     
mean 7.09 - 11.29 12.79 8.52 23.57  1.84 3.76 n/a 1.14 0.75  3.
2
9 
2.
4
4 
CMB00
8 
14.25 12.00 9.26 13.53 27.76 35.67     1.28   1.46         
 - - - - 12.09 31.29   2.59       
mean - - - - 19.93 33.48  2.47 1.94 0.84  2.15  1.
3
3 
1.
1
5 
CMB01
0 
6.96 7.03 11.11 16.67 11.20 46.81     4.18   1.50         
 11.62 12.23 9.20 18.46 14.34 39.33   2.74  2.01     
 7.00 16.14 17.48 18.42 27.96 57.53   2.06  1.05     
mean 8.53 11.80 12.60 17.85 17.83 47.89  2.68 2.99 1.38 1.52 1.42  1.
9
7 
1.
9
0 
CMB01
8 
5.90 11.31 7.97 7.88 30.47 48.84     1.60   0.99         
 9.67 9.61 9.41 8.64 11.23 27.91   2.49  0.92     
mean 7.79 10.46 8.69 8.26 20.85 38.38  4.65 2.04 1.34 0.95 2.40  2.
1
4 
1.
9
4 
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Experim
ent Code 
UNINF
ECTED 
WELL, 
NO 
TNF 
UNINF
ECTED 
WELL, 
+TNF 
UNINF
ECTED 
CELLS, 
NO 
TNF 
INFE
CTED 
CELL
S, NO 
TNF 
UNINF
ECTED 
CELLS, 
+TNF 
INFE
CTED 
CELL
S, 
+TNF 
 INF+T
NF/INF
-TNF 
INF+TNF/
Uninf+TNF 
within well 
ratio 
UNINF+TN
F/UNINF-
TNF (ALL 
UNINFEC
TED 
WELLS) 
INF-
TNF/ 
UNINF-
TNF 
within 
well 
ratio 
UNINF
+TNF/ 
UNINF
-TNF 
 J / 
L 
I/
M 
CMB01
9 
6.58 7.46 8.04 5.10 13.27 34.31     2.59   0.63         
 8.41 19.75 13.81 16.20 15.70 30.41   1.94  1.17     
mean 7.50 13.61 10.93 10.65 14.49 32.36  3.04 2.26 1.82 0.90 1.33  2.
5
0 
2.
2
9 
CMB02
1 
13.16 8.13 9.33 3.73 14.38 10.81     0.75   0.40         
 11.05 8.98 20.73 5.26 20.78 13.98   0.67  0.25     
 7.82 13.15 13.38 7.69 24.62 13.43   0.55  0.57     
mean 10.68 10.09 14.48 5.56 19.93 12.74  2.29 0.66 0.94 0.41 1.38  1.
6
0 
1.
6
7 
CMB02
9 
25.58 28.79 19.80 25.00 30.25 32.26     1.07   1.26         
 16.46 25.93 19.93 33.60 22.90 30.44   1.33  1.69     
mean 21.02 27.36 19.86 29.30 26.57 31.35  1.07 1.20 1.30 1.47 1.34  0.
8
1 
0.
8
0 
                
CMB03
1 
2.42 13.54 6.59 15.17 8.64 20.78     2.41   2.30         
 4.22 7.20 - - 13.13 23.34   1.78       
mean 3.32 10.37 - - 10.89 22.06  1.45 2.09 3.12  1.65  0.
9
1 
0.
8
8 
CMB04
0 
2.49 3.44 4.17 7.69 5.42 5.95     1.10   1.84         
 7.62 2.09 2.94 11.54 10.81 15.46   1.43  3.93     
mean 5.06 2.77 3.56 9.62 8.12 10.71  1.11 1.26 0.55 2.88 2.28  0.
4
4 
0.
4
9 
CMB07
5 
11.44 10.61 13.15 24.27 15.71 49.40     3.14   1.85         
 11.49 9.26 12.86 34.88 7.36 25.71   3.49  2.71     
 10.48 18.13 9.21 15.69 13.91 32.50   2.34  1.70     
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Experim
ent Code 
UNINF
ECTED 
WELL, 
NO 
TNF 
UNINF
ECTED 
WELL, 
+TNF 
UNINF
ECTED 
CELLS, 
NO 
TNF 
INFE
CTED 
CELL
S, NO 
TNF 
UNINF
ECTED 
CELLS, 
+TNF 
INFE
CTED 
CELL
S, 
+TNF 
 INF+T
NF/INF
-TNF 
INF+TNF/
Uninf+TNF 
within well 
ratio 
UNINF+TN
F/UNINF-
TNF (ALL 
UNINFEC
TED 
WELLS) 
INF-
TNF/ 
UNINF-
TNF 
within 
well 
ratio 
UNINF
+TNF/ 
UNINF
-TNF 
 J / 
L 
I/
M 
mean 11.14 12.67 11.74 24.95 12.33 35.87  1.44 2.99 1.14 2.09 1.05  1.
4
3 
1.
3
7 
CMB07
6 
11.89 7.25 10.20 22.90 3.40 14.90     4.38   2.25         
 11.00 8.05 11.60 16.10 7.90 31.40   3.97  1.39     
 12.43 14.12 17.16 28.40 12.10 43.10   3.56  1.66     
mean 11.77 9.81 12.99 22.47 7.80 29.80   1.33 3.97 0.83 1.76 0.60   2.
2
5 
2.
2
1 
                                
CMB07
7 
5.13 4.56 4.79 7.09 5.08 13.60   2.68  1.48     
(Mtb 
infectio
n) 
4.38 5.28 5.36 8.47 6.47 18.90   2.92  1.58     
 2.65 7.81 3.94 6.03 3.70 12.90   3.49  1.53     
 5.01 6.74 3.08 5.68 5.01 9.59   1.91  1.84     
 4.25 6.62 5.05 2.99 7.66 17.82   2.33  0.59     
 5.59 6.54 4.23 5.30 5.12 9.00   1.76  1.25     
mean 4.50 6.26 4.41 5.93 5.51 13.64   2.30 2.51 1.39 1.38 1.25   1.
8
2 
1.
8
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